Clinical Trials

NOT_YET_RECRUITING
Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)
To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which i...
Conditions:
Mesonephric-like Adenocarcinoma
Locations:
📍 Houston, Texas, United States
RECRUITING
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer
This study is set up as a phase I prospective, single center, device interventional pilot study carried in office setting under local anesthesia. It w...
Conditions:
Prostate Cancer Adverse Effects Surgery MRI Ultrasound
5 more conditions available...
Locations:
📍 Hialeah, Florida, United States
RECRUITING
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
This is a Phase I/Ib dose escalation, dose expansion, study to evaluate the safety and identify the recommended dose of modified immune cells PRGN-300...
Conditions:
Platinum-Resistant Fallopian Tube Carcinoma Platinum-Resistant Ovarian Carcinoma Platinum-Resistant Primary Peritoneal Carcinoma Recurrent Fallopian Tube Carcinoma
30 more conditions available...
Locations:
📍 Bethesda, Maryland, United States
📍 Seattle, Washington, United States
RECRUITING
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
The aim of the project is to evaluate the risk-reducing salpingectomy with delayed oophorectomy as an alternative for risk-reducing salpingo-oophorect...
Conditions:
BRCA1 Gene Mutation BRCA2 Gene Mutation RAD51C Gene Mutation RAD51D Gene Mutation
2 more conditions available...
Locations:
📍 Boston, Massachusetts, United States
📍 Rochester, Minnesota, United States
📍 Houston, Texas, United States
📍 Seattle, Washington, United States
33 more locations available...
RECRUITING
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
This early phase I trial evaluates blood samples to see if patients undergoing standard of care treatment with either stereotactic body radiation ther...
Conditions:
Metastatic Renal Cell Carcinoma Stage IV Renal Cell Cancer AJCC v8
Locations:
📍 Rochester, Minnesota, United States
RECRUITING
[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
The hypothesis of this exploratory clinical trial in patients with high-grade a primary brain tumor who receive chemoradiation is that the PET imaging...
Conditions:
Brain Tumor
Locations:
📍 Salt Lake City, Utah, United States
RECRUITING
Genetic Testing in African Americans
This is a pilot/feasibility study to conduct genetic testing using tumor/blood samples of African American and Caucasian patients with ovarian and end...
Conditions:
Ovarian Cancer Endometrial Cancer Peritoneal Cancer
Locations:
📍 Augusta, Georgia, United States
RECRUITING
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors
Patients may be considered if the cancer has come back, has not gone away after standard treatment or the patient cannot receive standard treatment. T...
Conditions:
Liver Cell Carcinoma Solid Tumor Wilms Tumor Malignant Rhabdoid Tumor
4 more conditions available...
Locations:
📍 Houston, Texas, United States
RECRUITING
Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer
This trial studies how well dabrafenib, trametinib, and intensity modulated radiation therapy (IMRT) work together in treating patients with BRAF muta...
Conditions:
BRAF NP_004324.2:p.V600E BRAF V600K Mutation Present Thyroid Gland Anaplastic Carcinoma
Locations:
📍 Duarte, California, United States
📍 Columbus, Ohio, United States
📍 Houston, Texas, United States
RECRUITING
Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
The number of elderly head-and-neck squamous cell carcinoma (HNSCC) patients is increasing; however, the evidence regarding the ideal treatment for th...
Conditions:
HNSCC Oral Cavity Cancer Oropharynx Cancer Hypopharynx Cancer
1 more condition available...
Locations:
📍 Baltimore, Maryland, United States
📍 New York, New York, United States
📍 Cleveland, Ohio, United States
📍 Columbus, Ohio, United States
10 more locations available...
RECRUITING
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
This clinical trial is studying advanced or metastatic solid tumors. Once a solid tumor has grown very large in one spot or has spread to other places...
Conditions:
Carcinoma, Squamous Cell of Head and Neck Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Endometrial Neoplasms
Locations:
📍 Chandler, Arizona, United States
📍 Los Angeles, California, United States
📍 Sacramento, California, United States
📍 Santa Rosa, California, United States
27 more locations available...
RECRUITING
Testing a New Imaging Agent to Identify Cancer
The purpose of this study is to see whether 89Zr-ss-pertuzumab is safe in people with HER2+ cancer.
Conditions:
HER-2 Positive Malignant Carcinoma of Breast HER-2 Protein Overexpression HER2-positive Metastatic Breast Cancer
Locations:
📍 Newport Beach, California, United States
📍 Basking Ridge, New Jersey, United States
📍 Middletown, New Jersey, United States
📍 Montvale, New Jersey, United States
4 more locations available...
RECRUITING
Breaking Through the Brain Fog: An Online Research Study
This study will investigate the benefits of distinct brain health trainings in breast cancer survivors (age 30-80) with cognitive concerns post-chemot...
Conditions:
Breast Cancer Female
Locations:
📍 Dallas, Texas, United States
RECRUITING
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
This phase I trial studies the best dose of total body irradiation when given with cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) or id...
Conditions:
Recurrent Acute Myeloid Leukemia Recurrent Chronic Myelomonocytic Leukemia Recurrent Myelodysplastic Syndrome Refractory Acute Myeloid Leukemia
5 more conditions available...
Locations:
📍 Seattle, Washington, United States
RECRUITING
Study of Personalized Cancer Therapy to Determine Response and Toxicity
The purpose of this study is to learn more about personalized cancer therapy including response to treatment and side effects. Information about the t...
Conditions:
Cancer
Locations:
📍 La Jolla, California, United States
📍 Rancho Mirage, California, United States
📍 San Diego, California, United States

Total Trials: 151 - 165 of 6772